These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22409272)

  • 1. Mechanisms of HIV-1 latency post HAART treatment area.
    Al-Harthi L; Kashanchi F
    Curr HIV Res; 2011 Dec; 9(8):552-3. PubMed ID: 22409272
    [No Abstract]   [Full Text] [Related]  

  • 2. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.
    Saksena NK; Potter SJ
    AIDS Rev; 2003; 5(1):3-18. PubMed ID: 12875103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1st International Workshop on HIV Persistence during Therapy. St. Martin, December 10-12, 2003.
    Tossing G
    Eur J Med Res; 2004 Feb; 9(2):83-6. PubMed ID: 15090294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attacking the HIV reservoir from the immune and viral perspective.
    Massanella M; Martinez-Picado J; Blanco J
    Curr HIV/AIDS Rep; 2013 Mar; 10(1):33-41. PubMed ID: 23242702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV reservoirs and strategies for eradication.
    Smith MZ; Wightman F; Lewin SR
    Curr HIV/AIDS Rep; 2012 Mar; 9(1):5-15. PubMed ID: 22249405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of viral reservoirs in HIV-1 infection.
    Blankson JN; Persaud D; Siliciano RF
    Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of RNA helicases in HIV-1 replication: possible roles in latency.
    Ajamian L; Mouland AJ
    Curr HIV Res; 2011 Dec; 9(8):588-94. PubMed ID: 22211663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
    Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
    Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of HIV-1 proviral latency.
    Bisgrove D; Lewinski M; Bushman F; Verdin E
    Expert Rev Anti Infect Ther; 2005 Oct; 3(5):805-14. PubMed ID: 16207172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.
    Coiras M; López-Huertas MR; Pérez-Olmeda M; Alcamí J
    Nat Rev Microbiol; 2009 Nov; 7(11):798-812. PubMed ID: 19834480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs.
    Metcalf Pate KA; Blankson JN
    Retrovirology; 2017 Nov; 14(1):52. PubMed ID: 29157283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.
    Persaud D; Ray SC; Kajdas J; Ahonkhai A; Siberry GK; Ferguson K; Ziemniak C; Quinn TC; Casazza JP; Zeichner S; Gange SJ; Watson DC
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):381-90. PubMed ID: 17411371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of HIV-1 persistence in the CD4+ T cell compartment: past, present and future.
    Tyagi M; Romerio F
    Curr HIV Res; 2011 Dec; 9(8):579-87. PubMed ID: 22211662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The search for a cure for persistent HIV reservoirs.
    Lafeuillade A; Stevenson M
    AIDS Rev; 2011; 13(2):63-6. PubMed ID: 21587339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is active hepatitis C associated with the size of HIV reservoir in successfully treated patients?
    Vassallo M; Durant J; Ticchioni M; Demonte A; Fabre R; Pradier C; Cottalorda J
    J Clin Virol; 2018 Nov; 108():103-104. PubMed ID: 30290324
    [No Abstract]   [Full Text] [Related]  

  • 16. Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication.
    Pomerantz RJ
    Clin Infect Dis; 2002 Jan; 34(1):91-7. PubMed ID: 11731950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV reservoir dynamics in the face of highly active antiretroviral therapy.
    Costiniuk CT; Jenabian MA
    AIDS Patient Care STDS; 2015 Feb; 29(2):55-68. PubMed ID: 25412339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latency and reservoirs for HIV-1.
    Siliciano RF
    AIDS; 1999; 13 Suppl A():S49-58. PubMed ID: 10885762
    [No Abstract]   [Full Text] [Related]  

  • 19. Humanized mouse models of HIV-1 latency.
    Duyne RV; Narayanan A; K-Hall K; Saifuddin M; Shultz L; Kashanchi F
    Curr HIV Res; 2011 Dec; 9(8):595-605. PubMed ID: 22211664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Reservoirs During Suppressive Therapy.
    Barton K; Winckelmann A; Palmer S
    Trends Microbiol; 2016 May; 24(5):345-355. PubMed ID: 26875617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.